Tag: CPhI Japan

CPhI Japan Expects Domestic Market to Grow

The report, published from CPhI Japan 2019, highlights the country as the second fasted growing mature market for solid dose drugs. Japan was also shown to be the second faster overall country for bio...

Japanese pharma industry energized by the next wave of growth

Japan’s pharmaceutical industry is the third largest worldwide after the US and China with a share of approximately ten percent of the world market and a value expected to reach $109 billion by 2026.

Pricing system reform and generics trend apparent at CPhI Japan 2018

Increased international generic API companies and suppliers are reported at next month’s CPhI Japan 2018, traditionally an innovative drug focussed market, due to recent changes in the country.

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation.